Author:
Rizzello Fernando,Salice Marco,Calabrese Carlo,Mazza Marta,Calafiore Andrea,Calandrini Lucia,Hrustemovic Hana Privitera,Campieri Massimo,Gionchetti Paolo
Reference81 articles.
1. Dignass A, Eliakim R, Magro F et al (2012) Second European evidence-based consensus on the diagnosis and management of ulcerative coliti. Part 1: Definitions and diagnosis. J Crohns Colitis 6(10):965–990
2. Silverberg MS, Satsangi J, Ahmad T et al (2005) Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 19(Suppl A): 5A–36A
3. Koutroubakis IE, Regueiro M, Schoen RE et al (2016) Multiyear patterns of serum inflammatory biomarkers and risk of colorectal neoplasia in patients with ulcerative colitis. Inflamm Bowel Dis 22(1):100–105
4. Kleer CG, Appelman HD (1998) Ulcerative colitis: patterns of involvement in colorectal biopsies and changes with time. Am J Surg Pathol 22(8):983–989
5. Magro F, Langner C, Driessen A et al; European Society of Pathology (ESP); European Crohn’s and Colitis Organisation (ECCO) (2013) European consensus on the histopathology of inflammatory bowel disease. J Crohns Colitis 7(10):827–851